Trial Profile
A Pilot Treatment Study of Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2012
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary)
- Indications Bipolar disorders; Obsessive-compulsive disorders
- Focus Therapeutic Use
- 12 Jul 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 19 Nov 2010 Planned End Date changed from Dec 2009 to Dec 2011 as reported by ClinicalTrials.gov.
- 30 Jan 2008 New trial record.